Titan Pharmaceuticals

PROBUPHINE

Manufacturer:

Titan Pharmaceuticals

Probuphine HCPCS:

J0570

HCPCS Code Descriptor:

Buprenorphine implant, 74.2 mg

Category:

J Code

Probuphine NDCs:

52440-0100-14

Primary Type:

Anti-Addiction

Generic/Specialty Status:

Single-Source

Route of Administration:

Intradermal

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

52440-0100-14

About Probuphine:

PROBUPHINE is an Anti-Addiction drug manufactured by Titan Pharmaceuticals and administered via the Intradermal route of administration. The J Code: J0570 is aligned to the drug PROBUPHINE.

ACCESS PRICING AND MORE BY REGISTERING

J0570 Added Date:

January 1, 2017

J0570 Effective Date:

January 1, 2017

J0570 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Probuphine billing and coding information.
Our team did not identify a source for Probuphine patient assistance information. Please reach out to our team if you feel that this is a mistake.
PROBUPHINE prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for PROBUPHINE. Please check back in a few weeks.